As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial ...

With winter on the horizon, hospitals across the UAE are preparing for a potential surge in respiratory syncytial virus (RSV) ...

While monoclonal antibodies have been approved to treat respiratory syncytial virus (RSV) in infants and young children in Germany, the German regulatory body for vaccinations—the German National ...

Please provide your email address to receive an email when new articles are posted on . A model predicted 17.5 to 22.6 million symptomatic RSV cases per year amongadults in the U.S. without a vaccine.

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

RSV significantly affects vulnerable older French adults, often causing repeat hospitalizations. Despite modern treatments, severe RSV illness can trigger lengthy hospital admissions, use of intensive ...

VIENNA, Austria, Oct. 26, 2025 (GLOBE NEWSWIRE) -- A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with ...

Although lack of routine testing and limitations to current diagnostic testing likely lead to underreporting of respiratory syncytial virus, RSV still poses a substantial economic burden. Respiratory ...

CNW/ - This RSV season, eight out of 10 Canadian newborns and infants will have access to Beyfortus, the first and only protective antibody approved in Canada for the prevention of RSV lower ...

Background. Limited data exist on the burden of respiratory syncytial virus (RSV) illness among pregnant women, to determine their potential benefit from RSV vaccination. We evaluated the incidence of ...

This RSV season, eight out of 10 Canadian newborns and infants will have access to Beyfortus, the first and only protective ...